Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
398 hedge funds and large institutions have $8.54B invested in Amedisys in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 149 increasing their positions, 144 reducing their positions, and 47 closing their positions.
13% more capital inflows, than outflows
Capital inflows: $501M | Capital outflows: $442M
3% more repeat investments, than reductions
Existing positions increased: 149 | Existing positions reduced: 144
0% more call options, than puts
Call options by funds: $54.8M | Put options by funds: $54.7M
0% more funds holding
Funds holding: 398 → 398 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.31% less ownership
Funds ownership: 89.02% → 88.71% (-0.31%)
19% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$94.5M |
| 2 |
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$55.7M |
| 3 |
Pictet Asset Management (UK)
London,
United Kingdom
|
+$32.2M |
| 4 |
Thornburg Investment Management
Santa Fe,
New Mexico
|
+$24.4M |
| 5 |
BlackRock
New York
|
+$23.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$46.9M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$35.2M |
| 3 |
Two Sigma Investments
New York
|
-$23.4M |
| 4 |
Marshall Wace North America
New York
|
-$21.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$18.5M |
AMED Hedge Fund Activity: Q4 2020 in Review
398 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2020, worth a combined $8.54B — up 25% from $6.83B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of AMED and 38 opened new positions — a net loss of 9 holders — while 144 trimmed existing stakes and 149 added.
The largest buyer was Invesco, adding an estimated $94.5M. The largest seller was Assenagon Asset Management, cutting an estimated $46.9M.
- 398 institutional investors held Amedisys (AMED) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $8.54B of Amedisys stock for Q4 2020, up 25% quarter-over-quarter.
- 38 funds opened new Amedisys positions in Q4 2020 and 47 closed out, a net change of -9 holders.
- The largest Amedisys buyer in Q4 2020 was Invesco, an estimated $94.5M added.
- The largest Amedisys seller in Q4 2020 was Assenagon Asset Management, an estimated $46.9M sold.
Based on aggregated 13F filings for Q4 2020.